SLC2A4 and cancer: Wei et al. reported that ritonavir, an HIV protease inhibitor, could reduce the expression of Mcl-1 and GLUT4, inhibit glucose consumption and cell proliferation, induce cell apoptosis, and increase the sensitivity of cancer cells to chemotherapeutic drugs (37, 38).